Ahmad Reza Dehpour | Pharmaceutical Science | Best Researcher Award

Best Researcher Award

Ahmad Reza Dehpour
Affiliation Tehran University of Medical Science
Country Iran
Scopus ID 7005678616
Documents 934
Citations 20,529
h-index 59
Subject Area Pharmaceutical Science
Event International Environmental Scientists Award
ORCID 0000-0002-8001-5565

Ahmad Reza Dehpour
Tehran University of Medical Sciences

Ahmad Reza Dehpour is affiliated with Tehran University of Medical Science in Iran and has a documented research profile in Pharmaceutical Science. The supplied Scopus record reports 934 documents, 20,529 citations, and an h-index of 59, providing substantial bibliometric evidence of scholarly activity and research influence. [1]

Abstract

Ahmad Reza Dehpour’s academic profile reflects extensive scholarly activity in Pharmaceutical Science, with an institutional affiliation at Tehran University of Medical Science. The supplied bibliometric record identifies 934 documents, 20,529 citations, and an h-index of 59, indicating a substantial publication and citation record. [1]

Keywords

Ahmad Reza Dehpour; Tehran University of Medical Science; Iran; Pharmaceutical Science; pharmacological research; drug research; biomedical science; publications; citations; h-index; research recognition.

Introduction

Pharmaceutical Science integrates drug discovery, pharmacology, formulation, therapeutic development, and related biomedical disciplines. Research within this field contributes to understanding medicines and their biological effects while supporting evidence-based approaches to pharmaceutical and healthcare innovation. [2]

Research Profile

The supplied profile identifies Ahmad Reza Dehpour with Tehran University of Medical Science and lists Pharmaceutical Science as the principal subject area. The Scopus author identifier is 7005678616, with 934 documents, 20,529 citations, and an h-index of 59 reported in the provided record. [1]

Research Contributions

A research profile of this scale indicates sustained scholarly engagement with pharmaceutical and pharmacological questions across a substantial body of scientific literature. Specific contributions should be assessed from individual publications, research findings, collaborations, and documented applications rather than from bibliometric indicators alone. [3]

Publications

The supplied Scopus information records 934 documents associated with the researcher. The available input does not specify individual article titles, journals, publication years, or article-level DOI identifiers; therefore, specific publications are not attributed in this profile. [1]

Research Impact

The supplied bibliometric record reports 20,529 citations and an h-index of 59. These measures indicate considerable citation activity within the indexed scholarly record, although citation metrics should be interpreted together with research quality, field-specific practices, collaboration, and substantive scientific contributions. [4]

Award Suitability

The documented publication volume, citation record, and h-index provide relevant quantitative evidence for consideration under a Best Researcher Award framework. Final eligibility and award selection should be determined through the official International Environmental Scientists Award nomination and evaluation procedures. [5]

Conclusion

Ahmad Reza Dehpour’s supplied academic record documents extensive research activity in Pharmaceutical Science, affiliation with Tehran University of Medical Science, and strong bibliometric indicators comprising 934 documents, 20,529 citations, and an h-index of 59. These indicators provide a quantitative foundation for academic recognition.

References

  1. Elsevier. (n.d.). Scopus author details: Ahmad Reza Dehpour, Author ID 7005678616. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005678616
  2. National Center for Biotechnology Information. (n.d.). PubMed and biomedical literature resources. National Library of Medicine.
    https://pubmed.ncbi.nlm.nih.gov/
  3. World Health Organization. (n.d.). Medicines and pharmaceutical research resources. World Health Organization.
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Environmental Scientists Award. (n.d.). Official Award Website.
    https://environmentalscientists.org/
  6. Crossref. (n.d.). DOI and scholarly metadata services. Crossref.

Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

Dr. Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

PhD candidate, Institute of drug discovery and development, Zhengzhou University, China

Nigatu Tadesse Gebrehiwot is a dedicated clinical pharmacist and PhD candidate in Pharmacology at Zhengzhou University, China πŸ‡¨πŸ‡³. With a strong background in drug safety, cancer care, and clinical trials, he combines research, patient-centered care, and academic writing to advance pharmaceutical sciences. Fluent in English (CEFR: C2) and well-versed in pharmacotherapy, Nigatu is recognized for his interdisciplinary expertise and contributions to national and international healthcare initiatives πŸŒπŸ’Š.

Profile

Orcid

πŸŽ“ Education

Nigatu earned his Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University πŸ‡¨πŸ‡³ (2016–2019), where he was honored for presenting research at the ISPOR European Congress in Barcelona. He completed his Bachelor of Pharmacy at Mekelle University πŸ‡ͺπŸ‡Ή (2009–2014), where he was celebrated as the most outstanding student. His academic journey reflects consistent excellence and passion for clinical research and therapeutic outcomes πŸ“šπŸ….

πŸ§ͺ Experience

Nigatu has held various impactful roles in healthcare and pharmaceutical research. As Principal Scientific Officer at Ethiopia’s Ministry of Health πŸ‡ͺπŸ‡Ή, he led disease management and national drug therapy protocols. He also served as Technical Manager at CBC Pharmacy, oversaw clinical pharmacy at Teklehaiymanot Hospital, and advised over 50 drug access projects for the Chinese market 🌍. Currently, he is pursuing a PhD in Pharmacology at Zhengzhou University, specializing in drug safety and clinical outcomes πŸ”¬πŸ©Ί.

πŸ”¬ Research Interest

Nigatu’s research interests span methionine metabolism in cancer, therapeutic drug evaluation, clinical trial outcomes, and antimicrobial therapy. He is particularly focused on immunotherapy, functional disease outcome measures, and innovative diagnostic methods. His goal is to improve patient care through translational and evidence-based pharmaceutical research πŸ’‘πŸ§¬.

πŸ† Awards

Nigatu received an award for his research abstract at the 21st European Congress ISPOR in Barcelona, Spain πŸ‡ͺπŸ‡Έ. He’s been acknowledged nationally and internationally for his scientific contributions and health policy initiatives. His ongoing membership in global societies like ISPOR, ISOPP, and ESMO underlines his excellence in pharmacology and healthcare outcome research πŸ₯‡πŸŒ.

πŸ“š Publications

Molecular Alterations in Gastric Intestinal Metaplasia (2025) – Biomedicines, 13(4):964
πŸ”— Read Article

Folate Species Analysis Challenges – Under revision in Bioanalysis

Methionine Metabolism in Immunotherapy – Under review in Novel Practice in Medical Study

Dioscorea zingiberensis Overview (2018) – Journal of Ethnopharmacology
πŸ”— Read Article

Toxicity of Dioscorea Extracts in Dogs (2017) – Regulatory Toxicology and Pharmacology
πŸ”— Read Article

Amide Alkaloid Synthesis and Anticancer Activity (2017) – Journal of Natural Product Research
πŸ”— Read Article

Wastewater Treatment in Diosgenin Production (2018) – Journal of Cleaner Production
πŸ”— Read Article

Antibiotic Prescribing in Sierra Leone – Royal Society of Tropical Medicine and Hygiene
πŸ”— Read Article

Self-Medication in Addis Ababa – Expert Review of Anti-infective Therapy
πŸ”— Read Article

Survival Time in HIV/TB Co-infection – Value in Health
πŸ”— Read Article

πŸ“ Conclusion

Mr. Nigatu Tadesse Gebrehiwot presents a strong and well-rounded profile suitable for the Best Researcher Award, especially within clinical pharmacology, health outcomes research, and drug safety. His multidisciplinary expertise, global engagement, and impactful publications showcase his excellence. With continued leadership in original research and enhanced visibility as principal investigator, he can solidify his position among the top-tier researchers internationally.